These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3935873)
41. Oral uracil/ftorafur (UFT) plus leucovorin as first-line chemotherapy and salvage therapy with weekly high-dose 5-fluorouracil/leucovorin for the treatment of metastatic colorectal cancer. Yang TS; Wang JY; Tang R; Hsu KC; Chen JS Jpn J Clin Oncol; 2002 Sep; 32(9):352-7. PubMed ID: 12417601 [TBL] [Abstract][Full Text] [Related]
42. [Locoregional chemotherapy of hepatic metastases of colorectal cancer]. Rougier P; Lasser P; Droz JP; Elias D; Ghosn M; Ducreux M; Lumbroso J; Sidibe S Ann Gastroenterol Hepatol (Paris); 1987 Nov; 23(6):315-9. PubMed ID: 2962534 [TBL] [Abstract][Full Text] [Related]
43. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Scheithauer W; Rosen H; Kornek GV; Sebesta C; Depisch D BMJ; 1993 Mar; 306(6880):752-5. PubMed ID: 7683942 [TBL] [Abstract][Full Text] [Related]
44. Phase I study of thymidine plus 5-fluorouracil infusions in advanced colorectal carcinoma. Vogel SJ; Presant CA; Ratkin GA; Klahr C Cancer Treat Rep; 1979 Jan; 63(1):1-5. PubMed ID: 369680 [TBL] [Abstract][Full Text] [Related]
45. Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a phase II study in patients with disseminated colorectal cancer. Leichman CG; Leichman L; Spears CP; Rosen PJ; Jeffers S; Groshen S J Natl Cancer Inst; 1993 Jan; 85(1):41-4. PubMed ID: 8416255 [TBL] [Abstract][Full Text] [Related]
46. [Role of pharmacokinetic monitoring of serum fluorouracil concentration in patients with local advanced and metastatic colorectal cancer and further improving efficacy of fluorouracil-based chemotherapy]. Cai X; Xue P; Song WF; Hu J; Gu HL; Yang HY; Wang LW Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):39-43. PubMed ID: 22490854 [TBL] [Abstract][Full Text] [Related]
47. [A retrospective study of irinotecan plus fluorouracil and l-leucovorin chemotherapy for advanced and metastatic colorectal cancer]. Kamoshita N; Makita F; Kobayashi M; Matsuzaki Y; Kabeya K Gan To Kagaku Ryoho; 2007 Mar; 34(3):397-401. PubMed ID: 17353631 [TBL] [Abstract][Full Text] [Related]
48. A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers. Ardalan B; Singh G; Silberman H J Clin Oncol; 1988 Jun; 6(6):1053-8. PubMed ID: 3373260 [TBL] [Abstract][Full Text] [Related]
49. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. Erlichman C; Fine S; Wong A; Elhakim T J Clin Oncol; 1988 Mar; 6(3):469-75. PubMed ID: 3280741 [TBL] [Abstract][Full Text] [Related]
50. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association. Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806 [TBL] [Abstract][Full Text] [Related]
51. [Biological effect of recombined leukocyte alpha-2-interferon in metastasizing colorectal cancers]. Niederle N; Kurschel E; Schmidt CG Dtsch Med Wochenschr; 1984 May; 109(20):779-82. PubMed ID: 6723531 [TBL] [Abstract][Full Text] [Related]
52. Protracted low-dose cisplatin infusion in advanced colorectal cancer. Lokich J; Zipoli T; Greene R; Paul S; Sonnenborn H; Moore C Cancer Treat Rep; 1986 Apr; 70(4):523-4. PubMed ID: 3698046 [TBL] [Abstract][Full Text] [Related]
53. Phase I study of protracted venous infusion of 5-fluorouracil. Lokich J; Bothe A; Fine N; Perri J Cancer; 1981 Dec; 48(12):2565-8. PubMed ID: 7306915 [TBL] [Abstract][Full Text] [Related]
54. Metastatic colorectal carcinoma. Response to hepatic infusion. A review. Donegan WL; Harris HS Mo Med; 1970 Mar; 67(3):163-8. PubMed ID: 4190052 [No Abstract] [Full Text] [Related]
55. 5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group. Colucci G; Maiello E; Gebbia V; Giuliani F; Serravezza G; Lelli G; Leo S; Filippelli G; Nicolella G; Brandi M Cancer; 1999 Feb; 85(3):535-45. PubMed ID: 10091727 [TBL] [Abstract][Full Text] [Related]
56. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer. Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394 [TBL] [Abstract][Full Text] [Related]
57. [Combination chemotherapy of continuous infusion 5-FU and daily low-dose CDDP in colorectal carcinoma]. Furuhata T; Hirata K; Yamamitsu S; Kimura H; Sasaki K; Hata F; Shirasaka T Gan To Kagaku Ryoho; 1999 Oct; 26(11):1554-8. PubMed ID: 10553412 [TBL] [Abstract][Full Text] [Related]